Effects of Vitamin D on Blood Pressure and Cardiovascular Risk Factors: A Randomized Controlled Trial

Hypertension

Volumn 65, Issue 6, 2015, Pages 1195-1201

  Pilz, Stefan ^a,b   Gaksch, Martin ^a   Kienreich, Katharina ^a   Grübler, Martin ^a   Verheyen, Nicolas ^a   Fahrleitner Pammer, Astrid ^a   Treiber, Gerlies ^a   Drechsler, Christiane ^c   Ó Hartaigh, Bríain ^d   Obermayer Pietsch, Barbara ^a   Schwetz, Verena ^a   Aberer, Felix ^a   Mader, Julia ^a   Scharnagl, Hubert ^a   Meinitzer, Andreas ^a   Lerchbaum, Elisabeth ^a   Dekker, Jacqueline M ^b   Zittermann, Armin ^e   März, Winfried ^a,f   Tomaschitz, Andreas ^a,g,h  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^e RUHR UNIVERSITY BOCHUM   (Germany)

^f SYNLAB ACADEMY   (Germany)

^g Specialist Clinic for Rehabilitation PV Bad Aussee   (Austria)

^h CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

blood pressure; cholecalciferol; placebo; randomized controlled trial; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; ALDOSTERONE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; COLECALCIFEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; PLACEBO; RENIN; TRIACYLGLYCEROL; VITAMIN D;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; AUSTRIA; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HOMEOSTASIS MODEL ASSESSMENT INSULIN RESISTANCE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MINERAL METABOLISM; MODEL; OUTPATIENT DEPARTMENT; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PULSE WAVE; QTC INTERVAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; UNIVERSITY HOSPITAL; URINARY EXCRETION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; AGED; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASES; COMPARATIVE STUDY; DIET SUPPLEMENTATION; DRUG EFFECTS; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY; REFERENCE VALUE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

AGED; AUSTRIA; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, UNIVERSITY; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VITAMIN D;

EID: 84937557159     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.05319     Document Type: Article

References (42)

1. Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2014;2:76-89. doi: 10.1016/S2213-8587(13)70165-7.
2. Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, Manson JE, Murad MH, Kovacs CS. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev. 2012;33:456-492. doi: 10.1210/er.2012-1000.
3. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab. 2012;97:1153-1158. doi: 10.1210/jc.2011-2601.
4. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96:53-58. doi: 10.1210/jc.2010-2704.
5. Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, Grant WB, Shoenfeld Y, Lerchbaum E, Llewellyn DJ, Kienreich K, Soni M. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-A review of recent evidence. Autoimmun Rev. 2013;12:976-989. doi: 10.1016/j.autrev.2013.02.004.
6. Pilz S, Gaksch M, OHartaigh B, Tomaschitz A, März W. The role of vitamin D deficiency in cardiovascular disease: where do we stand in 2013? Arch Toxicol. 2013;87:2083-2103. doi: 10.1007/s00204-013-1152-z.
7. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224-2260. doi: 10.1016/S0140-6736(12)61766-8.
8. Kunutsor SK, Apekey TA, Steur M. Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants. Eur J Epidemiol. 2013;28:205-221. doi: 10.1007/s10654-013-9790-2.
9. Kienreich K, Grubler M, Tomaschitz A, Schmid J, Verheyen N, Rutters F, Dekker JM, Pilz S. Vitamin D, arterial hypertension & cerebrovascular disease. Indian J Med Res. 2013;137:669-679.
10. Kunutsor SK, Burgess S, Munroe PB, Khan H. Vitamin D and high blood pressure: causal association or epiphenomenon? Eur J Epidemiol. 2014;29:1-14. doi: 10.1007/s10654-013-9874-z.
11. Witham MD, Price RJ, Struthers AD, Donnan PT, Messow CM, Ford I, McMurdo ME. Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial. JAMA Intern Med. 2013;173:1672-1679. doi: 10.1001/jamainternmed.2013.9043.
12. Scragg R, Slow S, Stewart AW, Jennings LC, Chambers ST, Priest PC, Florkowski CM, Camargo CA Jr, Murdoch DR. Long-term high-dose vitamin D3 supplementation and blood pressure in healthy adults: a randomized controlled trial. Hypertension. 2014;64:725-730. doi: 10.1161/HYPERTENSIONAHA.114.03466.
13. Arora P, Song Y, Dusek J, et al. Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial. Circulation. 2015;131:254-262. doi: 10.1161/CIRCULATIONAHA.114.011732.
14. Forman JP, Scott JB, Ng K, Drake BF, Suarez EG, Hayden DL, Bennett GG, Chandler PD, Hollis BW, Emmons KM, Giovannucci EL, Fuchs CS, Chan AT. Effect of vitamin D supplementation on blood pressure in blacks. Hypertension. 2013;61:779-785. doi: 10.1161/HYPERTENSIONAHA.111.00659.
15. Wood AD, Secombes KR, Thies F, Aucott L, Black AJ, Mavroeidi A, Simpson WG, Fraser WD, Reid DM, Macdonald HM. Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled RCT. J Clin Endocrinol Metab. 2012;97:3557-3568. doi: 10.1210/jc.2012-2126.
16. Larsen T, Mose FH, Bech JN, Hansen AB, Pedersen EB. Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am J Hypertens. 2012;25:1215-1222. doi: 10.1038/ajh.2012.111.
17. Dalbeni A, Scaturro G, Degan M, Minuz P, Delva P. Effects of six months of vitamin D supplementation in patients with heart failure: a randomized double-blind controlled trial. Nutr Metab Cardiovasc Dis. 2014;24:861-868 .doi: 10.1016/j.numecd.2014.02.015.
18. Witham MD, Ireland S, Houston JG, Gandy SJ, Waugh S, Macdonald TM, Mackenzie IS, Struthers AD. Vitamin D therapy to reduce blood pressure and left ventricular hypertrophy in resistant hypertension: randomized, controlled trial. Hypertension. 2014;63:706-712. doi: 10.1161/HYPERTENSIONAHA.113.02177.
19. Witham MD, Adams F, Kabir G, Kennedy G, Belch JJ, Khan F. Effect of short-term vitamin D supplementation on markers of vascular health in South Asian women living in the UK-A randomised controlled trial. Atherosclerosis. 2013;230:293-299. doi: 10.1016/j.atherosclerosis.2013.08.005.
20. Sollid ST, Hutchinson MY, Fuskevåg OM, Figenschau Y, Joakimsen RM, Schirmer H, Njølstad I, Svartberg J, Kamycheva E, Jorde R. No effect of high-dose vitamin D supplementation on glycemic status or cardiovascular risk factors in subjects with prediabetes. Diabetes Care. 2014;37:2123-2131. doi: 10.2337/dc14-0218.
21. Jorde R, Sneve M, Torjesen P, Figenschau Y. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med. 2010;267:462-472. doi: 10.1111/j.1365-2796.2009.02181.x.
22. Gepner AD, Ramamurthy R, Krueger DC, Korcarz CE, Binkley N, Stein JH. A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS One. 2012;7:e36617. doi: 10.1371/journal.pone.0036617.
23. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2006;83:754-759.
24. Kampmann U, Mosekilde L, Juhl C, Moller N, Christensen B, Rejnmark L, Wamberg L, Orskov L. Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency -A double-blind, randomized, placebo-controlled trial. Metabolism. 2014;63:1115-1124. doi: 10.1016/j.metabol.2014.06.008.
25. Jehle S, Lardi A, Felix B, Hulter HN, Stettler C, Krapf R. Effect of large doses of parenteral vitamin D on glycaemic control and calcium/phosphate metabolism in patients with stable type 2 diabetes mellitus: a randomised, placebo-controlled, prospective pilot study. Swiss Med Wkly. 2014;144:w13942. doi: 10.4414/smw.2014.13942.
26. Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab. 2001;86:1633-1637. doi: 10.1210/jcem.86.4.7393.
27. Wamberg L, Kampmann U, Stødkilde-Jørgensen H, Rejnmark L, Pedersen SB, Richelsen B. Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels -results from a randomized trial. Eur J Intern Med. 2013;24:644-649. doi: 10.1016/j.ejim.2013.03.005.
28. Suzuki M, Yoshioka M, Hashimoto M, Murakami M, Noya M, Takahashi D, Urashima M. Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease. Am J Clin Nutr. 2013;97:1004-1013. doi: 10.3945/ajcn.112.051664.
29. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.
30. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470.
31. OBrien E, Parati G, Stergiou G, et al; European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31:1731-1768. doi: 10.1097/HJH.0b013e328363e964.
32. Witham MD, Nadir MA, Struthers AD. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens. 2009;27:1948-1954. doi: 10.1097/HJH.0b013e32832f075b.
33. Vickers AJ, Altman DG. Statistics notes: analysing controlled trials with baseline and follow up measurements. BMJ. 2001;323:1123-1124.
34. Wang L, Song Y, Manson JE, Pilz S, März W, Michalsson K, Lundqvist A, Jassal SK, Barrett-Connor E, Zhang C, Eaton CB, May HT, Anderson JL, Sesso HD. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes. 2012;5:819-829. doi: 10.1161/CIRCOUTCOMES.112.967604.
35. Vimaleswaran KS, Cavadino A, Berry DJ, et al; LifeLines Cohort Study investigators; International Consortium for Blood Pressure (ICBP); Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium; Global Blood Pressure Genetics (Global BPGen) consortium; Caroline Hayward. Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study. Lancet Diabetes Endocrinol. 2014;2:719-729. doi: 10.1016/S2213-8587(14)70113-5.
36. Schroten NF, Ruifrok WP, Kleijn L, Dokter MM, Silljé HH, Lambers Heerspink HJ, Bakker SJ, Kema IP, van Gilst WH, van Veldhuisen DJ, Hillege HL, de Boer RA. Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an openlabel, blinded end point, randomized prospective trial (VitD-CHF trial). Am Heart J. 2013;166:357-364.e2. doi: 10.1016/j.ahj.2013.05.009.
37. Ford JA, MacLennan GS, Avenell A, Bolland M, Grey A, Witham M; RECORD Trial Group. Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. Am J Clin Nutr. 2014;100:746-755. doi: 10.3945/ajcn.113.082602.
38. Challoumas D. Vitamin D supplementation and lipid profile: what does the best available evidence show? Atherosclerosis. 2014;235:130-139. doi: 10.1016/j.atherosclerosis.2014.04.024.
39. Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet. 2000;355: 1064-1069. doi: 10.1016/S0140-6736(00)02039-0.
40. Vieth R, Chan PC, MacFarlane GD. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr. 2001;73:288-294.
41. Kupferschmidt K. Uncertain verdict as vitamin D goes on trial. Science. 2012;337:1476-1478. doi: 10.1126/science.337.6101.1476.
42. Pilz S, Rutters F, Dekker JM. Disease prevention: vitamin D trials. Science. 2012;338:883. doi: 10.1126/science.338.6109.883-c.